Does TECLISTAMAB-CQYV Cause Status epilepticus? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Status epilepticus have been filed in association with TECLISTAMAB-CQYV. This represents 0.4% of all adverse event reports for TECLISTAMAB-CQYV.
6
Reports of Status epilepticus with TECLISTAMAB-CQYV
0.4%
of all TECLISTAMAB-CQYV reports
0
Deaths
6
Hospitalizations
How Dangerous Is Status epilepticus From TECLISTAMAB-CQYV?
Of the 6 reports, 6 (100.0%) required hospitalization, and 3 (50.0%) were considered life-threatening.
Is Status epilepticus Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB-CQYV. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB-CQYV Cause?
Cytokine release syndrome (406)
Immune effector cell-associated neurotoxicity syndrome (153)
Off label use (122)
Death (116)
Plasma cell myeloma (96)
Infection (83)
Neutropenia (74)
Fatigue (72)
Pyrexia (67)
Covid-19 (64)
What Other Drugs Cause Status epilepticus?
LEVETIRACETAM (1,883)
LACOSAMIDE (874)
VALPROIC ACID (587)
PHENYTOIN (544)
BUPROPION (490)
LAMOTRIGINE (438)
MIDAZOLAM (369)
CLOBAZAM (366)
PHENOBARBITAL (317)
TOPIRAMATE (315)
Which TECLISTAMAB-CQYV Alternatives Have Lower Status epilepticus Risk?
TECLISTAMAB-CQYV vs TEDIZOLID
TECLISTAMAB-CQYV vs TEDUGLUTIDE
TECLISTAMAB-CQYV vs TEDUGLUTIDE\WATER
TECLISTAMAB-CQYV vs TEGAFUR
TECLISTAMAB-CQYV vs TEGAFUR\URACIL